Cargando…

Evaluation of the Charlson Comorbidity Index and Laboratory Parameters as Independent Early Mortality Predictors in Covid 19 Patients

PURPOSE: Various parameters have been proposed to predict the outcome of patients with coronavirus disease. The aim of this study was to evaluate the utility of the age-adjusted CCI score and biochemical parameters for predicting outcomes for COVID-19 patients on admission. PATIENTS AND METHODS: A t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cavuşoğlu Türker, Betül, Türker, Fatih, Ahbab, Süleyman, Hoca, Emre, Urvasızoğlu, Ayşe Oznur, Cetin, Seher Irem, Ataoğlu, Hayriye Esra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343174/ https://www.ncbi.nlm.nih.gov/pubmed/35924178 http://dx.doi.org/10.2147/IJGM.S374246

Ejemplares similares

Serum albumin and FT3/FT4 ratio as additional co-morbidity parameters to predict mortality as a new approach: The Haseki Scoring Index (updated Charlson Comorbidity Index)
por: Cavusoglu Turker, Betul, et al.
Publicado: (2022)

Systemic Immune-Inflammation and Systemic Inflammation Response Indices are Predictive Markers of Mortality in Inpatients Internal Medicine Services
por: Çavuşoğlu Türker, Betül, et al.
Publicado: (2023)

FT3/FT4 ratio predicts non-alcoholic fatty liver disease independent of metabolic parameters in patients with euthyroidism and hypothyroidism
por: Gökmen, Fatma Yahyaoğlu, et al.
Publicado: (2016)

Does the FT3-to-FT4 ratio easily predict the progression of NAFLD and NASH cirrhosis?
por: Türker, Fatih, et al.
Publicado: (2021)

Evaluation of Predisposing Metabolic Risk Factors for Portopulmonary Hypertension in Patients with NASH Cirrhosis
por: Türker, Fatih, et al.
Publicado: (2022)

Prediabetes and Type 2 Diabetes are Independent Risk Factors for Computed Tomography-Estimated Nonalcoholic Fatty Pancreas Disease
por: Ahbab, Süleyman, et al.
Publicado: (2019)

Neck circumference, metabolic syndrome and obstructive sleep apnea syndrome; Evaluation of possible linkage
por: Ahbab, Süleyman, et al.
Publicado: (2013)

Vitamin D Deficiency Is a Potential Risk for Blood Pressure Elevation and the Development of Hypertension
por: Karadeniz, Yusuf, et al.
Publicado: (2021)

An electronic application for rapidly calculating Charlson comorbidity score
por: Hall, William H, et al.
Publicado: (2004)

Sjögren syndrome presenting with hypopotassemic periodic paralysis due to renal tubular acidosis
por: Ataoglu, Esra Hayriye, et al.
Publicado: (2012)

Comparative evaluation of the clinical laboratory-based Intermountain risk score with the Charlson and Elixhauser comorbidity indices for mortality prediction
por: Snow, Gregory L., et al.
Publicado: (2020)

Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden
por: Ludvigsson, Jonas F, et al.
Publicado: (2021)

Analysis of the Impact of Comorbidities on Endometrial Lesions Using the Charlson Comorbidity Index in Western Romania
por: Furau, Alexandru, et al.
Publicado: (2021)

Recalibration and Validation of the Charlson Comorbidity Index in Korean Incident Hemodialysis Patients
por: Park, Jae Yoon, et al.
Publicado: (2015)

Charlson comorbidity index as a predictor of periodontal disease in elderly participants
por: Lee, Jae-Hong, et al.
Publicado: (2018)

Developing an adapted Charlson comorbidity index for ischemic stroke outcome studies
por: Hall, Ruth E., et al.
Publicado: (2019)

National Norms for the Elixhauser and Charlson Comorbidity Indexes Among Hospitalized Adults
por: Loyd, Christine, et al.
Publicado: (2021)

The prognostic value of the Charlson comorbidity index in aged patients with intracerebral hemorrhage
por: Zhang, Tianjie, et al.
Publicado: (2022)

Charlson comorbidity index applied to shunted idiopathic normal pressure hydrocephalus
por: Klinge, Petra M., et al.
Publicado: (2023)

Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden [Corrigendum]
Publicado: (2023)

The Relationship between Post-COVID Syndrome and the Burden of Comorbidities Assessed Using the Charlson Comorbidity Index
por: Falsetti, Lorenzo, et al.
Publicado: (2023)

Charlson Comorbidity Index (CCI) in Diffuse Large B-cell Lymphoma: A New Approach in a Multicenter Study
por: Eren, Rafet, et al.
Publicado: (2022)

Age-adjusted Charlson comorbidity score is associated with the risk of empyema in patients with COPD
por: Ho, Chung-Han, et al.
Publicado: (2017)

Age-adjusted charlson comorbidity index and 30-day morbidity in pelvic surgeries
por: Dessai, Sampada B., et al.
Publicado: (2018)

The relationship of Charlson comorbidity index with stent restenosis and extent of coronary artery disease
por: Karabağ, Turgut, et al.
Publicado: (2018)

The Age-Adjusted Charlson Comorbidity Index Predicts Prognosis in Elderly Cancer Patients
por: Zhou, Shi, et al.
Publicado: (2022)

Charlson Comorbidity Index as a Predictor of Difficult Cholecystectomy in Patients With Acute Cholecystitis
por: Alburakan, Ahmed A, et al.
Publicado: (2022)

Effects of comorbidities and functional living activities on survival in geriatric breast cancer patients
por: Sonmez, Ozlem U., et al.
Publicado: (2014)

Prognosis models for severe and critical COVID-19 based on the Charlson and Elixhauser comorbidity indices
por: Zhou, Wei, et al.
Publicado: (2020)

Charlson comorbidity index as a predictor of short-term outcomes after pulmonary resection
por: Shao, Weipeng, et al.
Publicado: (2020)

Does the Charlson comorbidity index help predict the risk of death in COVID-19 patients?
por: Comoglu, Senol, et al.
Publicado: (2022)

Simple Excel and ICD-10 based dataset calculator for the Charlson and Elixhauser comorbidity indices
por: Prommik, Pärt, et al.
Publicado: (2022)

Age-adjusted Charlson comorbidity index in recurrent glioblastoma: a new prognostic factor?
por: Barz, Melanie, et al.
Publicado: (2022)

Charlson Comorbidity Index in Predicting Poor Clinical Outcomes and Mortality in Patients with COVID-19
por: Argun Barış, Serap, et al.
Publicado: (2022)

A study of factors impacting disease based on the Charlson Comorbidity Index in UK Biobank
por: Wang, Changcong, et al.
Publicado: (2023)

The Prognostic Value of the Age-Adjusted Charlson Comorbidity Index Among the Elderly with Breast Cancer
por: Wang, Zhe, et al.
Publicado: (2023)

Circulating mir-200c and mir-33a may be used as biomarkers for predicting high fructose corn syrup-induced fatty liver and vitamin D supplementation-related liver changes
por: TANOĞLU, Alpaslan, et al.
Publicado: (2022)

Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases
por: Li, Bing, et al.
Publicado: (2008)

Comparison of Charlson comorbidity index with SAPS and APACHE scores for prediction of mortality following intensive care
por: Christensen, Steffen, et al.
Publicado: (2011)

The Association between Charlson Comorbidity Index and the Medical Care Cost of Cancer: A Retrospective Study
por: Yoon, Seok-Jun, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_godbh12he2auadi5gp464v7rvk